In summary, by incorporating functional information and conducting aggregated gene‐based testing, the most significant interactions we observed where between FOXA1 and BMI among men, and between PTPN2 and diabetes for CRC risk. This evidence concerns the gene FOXA1 and diabetes mellitus.